Nicholas Keen, Chief Scientific Officer at BICYCLE THERAPEUTICS plc (BCYC), sold 5,544 shares at $45.10 ($250K) on 2021-10-05, disclosed to the SEC on 2021-10-05.
Open-market sale of $250k BCYC by Chief Scientific Officer. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $45.00 | 1,188 | $53K | 21.4% |
| 2 | $45.10 | 2,178 | $98K | 39.3% |
| 3 | $45.10 | 2,178 | $98K | 39.3% |
| Total | $45.08 avg | 5,544 | $250K | 100% |
| Filing → |
| BCYC | SELL | 2024-01-04 | $46K | — | Filing → |
| BCYC | SELL | 2023-10-05 | $5K | — | Filing → |
| BCYC | SELL | 2023-07-06 | $8K | — | Filing → |